21 research outputs found
Phase behaviour of additive binary mixtures in the limit of infinite asymmetry
We provide an exact mapping between the density functional of a binary
mixture and that of the effective one-component fluid in the limit of infinite
asymmetry. The fluid of parallel hard cubes is thus mapped onto that of
parallel adhesive hard cubes. Its phase behaviour reveals that demixing of a
very asymmetric mixture can only occur between a solvent-rich fluid and a
permeated large particle solid or between two large particle solids with
different packing fractions. Comparing with hard spheres mixtures we conclude
that the phase behaviour of very asymmetric hard-particle mixtures can be
determined from that of the large component interacting via an adhesive-like
potential.Comment: Full rewriting of the paper (also new title). 4 pages, LaTeX, uses
revtex, multicol, epsfig, and amstex style files, to appear in Phys. Rev. E
(Rapid Comm.
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
BACKGROUND: Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects, to clarify the phenomenology of the harms associated with mefloquine, and to make recommendations for safer prescribing. PRESENTATION: We postulate that many of the adverse effects of mefloquine are a post-hepatic syndrome caused by primary liver damage. In some users we believe that symptomatic thyroid disturbance occurs, either independently or as a secondary consequence of the hepatocellular injury. The mefloquine syndrome presents in a variety of ways including headache, gastrointestinal disturbances, nervousness, fatigue, disorders of sleep, mood, memory and concentration, and occasionally frank psychosis. Previous liver or thyroid disease, and concurrent insults to the liver (such as from alcohol, dehydration, an oral contraceptive pill, recreational drugs, and other liver-damaging drugs) may be related to the development of severe or prolonged adverse reactions to mefloquine. IMPLICATIONS: We believe that people with active liver or thyroid disease should not take mefloquine, whereas those with fully resolved neuropsychiatric illness may do so safely. Mefloquine users should avoid alcohol, recreational drugs, hormonal contraception and co-medications known to cause liver damage or thyroid damage. With these caveats, we believe that mefloquine may be safely prescribed in pregnancy, and also to occupational groups who carry out safety-critical tasks. TESTING: Mefloquine's adverse effects need to be investigated through a multicentre cohort study, with small controlled studies testing specific elements of the hypothesis
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
Background
Beta-blockers, used as an adjunctive to diuretics, digoxin and angiotensin converting enzyme inhibitors, improve survival in chronic heart failure. We report a prospectively planned economic analysis of the cost of adjunctive beta-blocker therapy in the second Cardiac Insufficiency BIsoprolol Study (CIBIS II).
Methods
Resource utilization data (drug therapy, number of hospital admissions, length of hospital stay, ward type) were collected prospectively in all patients in CIBIS . These data were used to determine the additional direct costs incurred, and savings made, with bisoprolol therapy. As well as the cost of the drug, additional costs related to bisoprolol therapy were added to cover the supervision of treatment initiation and titration (four outpatient clinic/office visits). Per them (hospital bed day) costings were carried out for France, Germany and the U.K. Diagnosis related group costings were performed for France and the U.K. Our analyses took the perspective of a third party payer in France and Germany and the National Health Service in the U.K.
Results
Overall, fewer patients were hospitalized in the bisoprolol group, there were fewer hospital admissions perpatient hospitalized, fewer hospital admissions overall, fewer days spent in hospital and fewer days spent in the most expensive type of ward. As a consequence the cost of care in the bisoprolol group was 5-10% less in all three countries, in the per them analysis, even taking into account the cost of bisoprolol and the extra initiation/up-titration visits. The cost per patient treated in the placebo and bisoprolol groups was FF35 009 vs FF31 762 in France, DM11 563 vs DM10 784 in Germany and pound 4987 vs pound 4722 in the U.K. The diagnosis related group analysis gave similar results.
Interpretation
Not only did bisoprolol increase survival and reduce hospital admissions in CIBIS II, it also cut the cost of care in so doing. This `win-win' situation of positive health benefits associated with cost savings is Favourable from the point of view of both the patient and health care systems. These findings add further support for the use of beta-blockers in chronic heart failure
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry
High-Level Synthesis Assisted Rapid Prototyping for Digital Signal Processing
The increasing needs of higher data rates associated with mobility constraints motivate the development of Digital Satellite News Gathering (DSNG) and Digital Video Broadcasting applications by Satellite (DVB_S). Error control codes like Reed-Solomon and Viterbi codes are widely used in these communication systems against channel noise. Traditional methods for rapid prototyping of hardware cores for this kind of applications are based on RTL specifications However, they suffer from heavy limitations that prevent them from efficiently addressing both the algorithmic complexity and the high flexibility required by the various application profiles in fast implementation and prototyping issues. For this reasons, we propose to reduce hardware IP core development time by benefiting from the emerging High-Level Synthesis (HLS) tools in a platform-based approach dedicated to rapid prototyping. This technique has been successfully applied to the design of Reed-Solomon (RS) and Viterbi decoder IP cores for the DVB-DSNG standard and can be easily extended to many DSP dataflow applications